Spo Medical Inc (SPOM) 0.0135 $SPOM
CHS reports $242.2 million first-quarter earnings for fiscal 2014
PR Newswire - Wed Jan 08, 3:00PM CST
CHS Inc. (NASDAQ: CHSCP), the nation's leading farmer-owned cooperative and a global energy, grains and foods company, today reported net income of $242.2 million for the first quarter of its 2014 fiscal year.
SPO Reports Results for Second Quarter 2013
PR Newswire - Tue Aug 20, 8:15AM CDT
SPO (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced recently its financial results for the fiscal quarter ended June 30, 2013.
SPO Reports Results for First Quarter 2013
PR Newswire - Mon May 13, 3:30PM CDT
SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today financial results for the fiscal quarter ended March 31, 2013.
SPO Returns to Revenue Generation
PR Newswire - Thu Apr 11, 1:40PM CDT
SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today financial results for the year ended December 31, 2012. During this period the Company completed development of its new wellness product and commenced sales activities.
Health Care Penny Stocks On The Move: (OTCQB: SPOM), (OTCQB: AMAR)
ACCESSWIRE-TNW - Thu Feb 21, 12:42PM CST
New York (February 21st, 2013) - SPO Medical Inc. (OTCQB: SPOM) shows neutral trend as the stock made a sharp down movement in its latest trading session. It opened the session at $0.03 and remained in $0.0168 and $0.025 price range during the session. The stock is 9.55 percent lower at $0.0199. SPO Medical's first support level is at $0.0195. Upon breaching this level, the stock may go as low as $0.0185. On the upside, its first resistance level is at $0.02.
SPO Partners with HoMedics LLC
PR Newswire - Tue Feb 19, 7:30AM CST
SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today that it has partnered with HoMedics LLC for the distribution of a private-labeled, over-the-counter (OTC) pulse oximeter for non-medical consumer wellness applications. This new product, known as the HoMedics Deluxe Pulse Oximeter is currently being promoted and sold in North America.
CHS reports $242.2 million first-quarter earnings for fiscal 2014
PR Newswire - Wed Jan 08, 3:00PM CST
CHS Inc. (NASDAQ: CHSCP), the nation's leading farmer-owned cooperative and a global energy, grains and foods company, today reported net income of $242.2 million for the first quarter of its 2014 fiscal year.
SPO Reports Results for Second Quarter 2013
PR Newswire - Tue Aug 20, 8:15AM CDT
SPO (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced recently its financial results for the fiscal quarter ended June 30, 2013.
SPO Reports Results for First Quarter 2013
PR Newswire - Mon May 13, 3:30PM CDT
SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today financial results for the fiscal quarter ended March 31, 2013.
SPO Returns to Revenue Generation
PR Newswire - Thu Apr 11, 1:40PM CDT
SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today financial results for the year ended December 31, 2012. During this period the Company completed development of its new wellness product and commenced sales activities.
Health Care Penny Stocks On The Move: (OTCQB: SPOM), (OTCQB: AMAR)
ACCESSWIRE-TNW - Thu Feb 21, 12:42PM CST
New York (February 21st, 2013) - SPO Medical Inc. (OTCQB: SPOM) shows neutral trend as the stock made a sharp down movement in its latest trading session. It opened the session at $0.03 and remained in $0.0168 and $0.025 price range during the session. The stock is 9.55 percent lower at $0.0199. SPO Medical's first support level is at $0.0195. Upon breaching this level, the stock may go as low as $0.0185. On the upside, its first resistance level is at $0.02.
SPO Partners with HoMedics LLC
PR Newswire - Tue Feb 19, 7:30AM CST
SPO Medical Inc. (SPOM), a leading developer of biosensor and microprocessor technologies for use in portable monitoring devices, announced today that it has partnered with HoMedics LLC for the distribution of a private-labeled, over-the-counter (OTC) pulse oximeter for non-medical consumer wellness applications. This new product, known as the HoMedics Deluxe Pulse Oximeter is currently being promoted and sold in North America.
